Toll-like receptor 4-Mitogen-activated protein kinase signaling axis (TLR4-MAPK axis)

The Toll-like receptor 4 (TLR4)-Mitogen-activated protein kinase (MAPK) signaling axis is a fundamental pathway in the innate immune system responsible for detecting pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) (UniProt: O00206). Activation begins when TLR4 binds to ligands such as lipopolysaccharide (LPS), leading to the recruitment of intracellular adapter proteins like MyD88 and TRIF (PubMed: 30214615). These adapters initiate a phosphorylation cascade that activates the MAPK family, including p38, c-Jun N-terminal kinase (JNK), and extracellular signal-regulated kinase (ERK) (PubMed: 25035185). Once activated, these kinases translocate to the nucleus to regulate transcription factors that drive the expression of pro-inflammatory cytokines like TNF-alpha and IL-6. Dysregulation of this axis is a hallmark of various pathological conditions, including septic shock, rheumatoid arthritis, and neurodegenerative diseases (PubMed: 23512140). In oncology, chronic activation of the TLR4-MAPK pathway can promote tumor cell proliferation, migration, and resistance to apoptosis. Pharmacological intervention typically involves TLR4 antagonists, such as Resatorvid (TAK-242), or small molecule inhibitors targeting specific downstream MAPKs to dampen the inflammatory response (PubChem CID: 11491033). However, therapeutic targeting is challenging due to the pathway's essential role in host defense, requiring a delicate balance to avoid severe immunosuppression.

Other names

TLR4-MAPK pathwayTLR4/MAPK signaling cascadeTLR4-mediated MAPK activation

Inhibition of TLR4-mediated ligand recognition or the subsequent phosphorylation cascade of downstream mitogen-activated protein kinases to suppress inflammatory gene transcription.